SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC

LPL Financial LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 641,784 shares of the exchange traded fund’s stock after selling 52,593 shares during the period. LPL Financial LLC owned about 0.84% of SPDR S&P Biotech ETF worth $57,799,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of XBI. Proficio Capital Partners LLC raised its position in shares of SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after acquiring an additional 911,686 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $55,529,000. Whittier Trust Co. lifted its position in shares of SPDR S&P Biotech ETF by 3.1% during the 4th quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after buying an additional 9,713 shares during the last quarter. J.Safra Asset Management Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after buying an additional 240,415 shares in the last quarter. Finally, Stifel Financial Corp grew its position in shares of SPDR S&P Biotech ETF by 20.8% in the 3rd quarter. Stifel Financial Corp now owns 288,109 shares of the exchange traded fund’s stock valued at $28,466,000 after buying an additional 49,550 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $85.53 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The stock has a market cap of $5.54 billion, a PE ratio of 11.47 and a beta of 0.99. The firm has a fifty day moving average price of $89.48 and a 200 day moving average price of $94.06.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.